Literature DB >> 1596694

Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.

M Waelbroeck1, J Camus, M Tastenoy, J Christophe.   

Abstract

1. We compared the binding properties of 4-diphenyl-acetoxy-N-methyl-piperidine methiodide (4-DAMP) and nine analogues of this compound on muscarinic receptors of human neuroblastoma NB-OK1 cells (M1 subtype), rat heart (M2 subtype), rat pancreas (M3 subtype) and to the putative M4 subtype in striatum. 2. The requirements for high affinity binding were somewhat different for the four receptor subtypes. In general, the requirements of M3 receptors were more stringent than for M1, M2 or putative M4 receptors. 3. The abilities of the compounds to discriminate muscarinic receptor subtypes were not correlated with their affinities at any subtype. 4. The temperature-dependence of binding of 4-DAMP analogues to M2 receptors varied with the drug structure. In particular, the increased affinity of the alpha-methyl derivative of 4-DAMP could be ascribed to van der Waals interactions. 5. The affinities of most 4-DAMP analogues for M2 and M3 receptors were similar to their pharmacological potencies on atrial and ileum preparations, respectively. 6. At concentrations above 1 microM, all 4-DAMP analogues as well as atropine, reduced the [3H]-N-methyl scopolamine ([3H]-NMS) dissociation rate from cardiac muscarinic receptors, with no obvious structure-activity relationship.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596694      PMCID: PMC1908626          DOI: 10.1111/j.1476-5381.1992.tb14217.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  80% of muscarinic receptors expressed by the NB-OK 1 human neuroblastoma cell line show high affinity for pirenzepine and are comparable to rat hippocampus M1 receptors.

Authors:  M Waelbroeck; J Camus; M Tastenoy; J Christophe
Journal:  FEBS Lett       Date:  1988-01-04       Impact factor: 4.124

3.  Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.

Authors:  M Waelbroeck; M Gillard; P Robberecht; J Christophe
Journal:  Mol Pharmacol       Date:  1987-07       Impact factor: 4.436

4.  Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors.

Authors:  H N Doods; M J Mathy; D Davidesko; K J van Charldorp; A de Jonge; P A van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.

Authors:  M Waelbroeck; J Camus; J Winand; J Christophe
Journal:  Life Sci       Date:  1987-11-09       Impact factor: 5.037

7.  Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.

Authors:  S Lazareno; N J Buckley; F F Roberts
Journal:  Mol Pharmacol       Date:  1990-12       Impact factor: 4.436

8.  A further search for selective antagonists at M2-muscarinic receptors.

Authors:  R B Barlow; M K Shepherd
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

9.  Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.

Authors:  E Giraldo; R Micheletti; E Montagna; A Giachetti; M A Viganò; H Ladinsky; C Melchiorre
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

10.  Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.

Authors:  R Hammer; E Giraldo; G B Schiavi; E Monferini; H Ladinsky
Journal:  Life Sci       Date:  1986-05-05       Impact factor: 5.037

View more
  6 in total

Review 1.  Allosteric drugs acting at muscarinic acetylcholine receptors.

Authors:  Magali Waelbroeck
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 2.  Rational design of dualsteric GPCR ligands: quests and promise.

Authors:  Klaus Mohr; Christian Tränkle; Evi Kostenis; Elisabetta Barocelli; Marco De Amici; Ulrike Holzgrabe
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

3.  Nitric oxide-dependent relaxation induced by M1 muscarinic receptor activation in the rat small intestine.

Authors:  C Olgart; H H Iversen
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Transcriptional up-regulation of nitric oxide synthase II by nuclear factor-kappaB at rostral ventrolateral medulla in a rat mevinphos intoxication model of brain stem death.

Authors:  Julie Y H Chan; Carol H Y Wu; Ching-Yi Tsai; Hsiao-Lei Cheng; Kuang-Yu Dai; Samuel H H Chan; Alice Y W Chang
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

5.  2-Ethyl-piperidinium chloride.

Authors:  Mohammad T M Al-Dajani; Jamal Talaat; Abdusalam Salhin; Madhukar Hemamalini; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-09-17

6.  (2,6-Difluoro-phen-yl)(4-methyl-piperidin-1-yl)methanone.

Authors:  Mohammad T M Al-Dajani; Hassan H Adballah; Nornisah Mohamed; Madhukar Hemamalini; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.